How long does it take to take lvosidenib? How long does it take for it to be effective?

Ivosidenib is suitable for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with IDH1mutations(AML), is also suitable for age Adults ≥75 years of age who are newly diagnosed with IDH1mutationsAML or who have comorbidities that preclude the use of intensive induction chemotherapy, with or without azacitidine. Avosidenib is indicated for the treatment of locally advanced or metastatic cholangiocarcinoma in adult patients with susceptibility IDH1 mutations who have received treatment.

The recommended dose of ivonib is 500 mg taken orally once daily until disease progression or unacceptable toxicity. For patients without disease progression or unacceptable toxicity, treat for at least 6 months to allow time for clinical response. The most common adverse reactions of ivosidenib (≥20%) are fatigue, arthralgia, leukocytosis, diarrhea, edema, nausea, dyspnea, mucositis, electrocardiogramQT prolongation, rash, cough, decreased appetite, myalgia, constipation and fever. The most common laboratory abnormalities (≥20%)are decreased hemoglobin, decreased calcium, decreased sodium, decreased magnesium, increased uric acid, decreased potassium, increased alkaline phosphatase, increased aspartate aminotransferase, decreased phosphate, and increased creatinine. Patients receiving TIBSOVO developed symptoms of differentiation syndrome, which can be fatal if left untreated. If differentiation syndrome is suspected, initiate corticosteroid therapy and hemodynamic monitoring until symptoms resolve. If you want to get more high-quality information, you can contact Yaodede. Yaode will do its best to learn more about high-quality overseas drugs for you.